197 related articles for article (PubMed ID: 32093678)
21. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
Almeida M; Cordero M; Almeida J; Orfao A
Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
[TBL] [Abstract][Full Text] [Related]
22. The majority of HIV type 1 DNA in circulating CD4+ T lymphocytes is present in non-gut-homing resting memory CD4+ T cells.
McBride K; Xu Y; Bailey M; Seddiki N; Suzuki K; Murray JM; Gao Y; Yan C; Cooper DA; Kelleher AD; Koelsch KK; Zaunders J
AIDS Res Hum Retroviruses; 2013 Oct; 29(10):1330-9. PubMed ID: 23971972
[TBL] [Abstract][Full Text] [Related]
23. Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy.
Lee E; Bacchetti P; Milush J; Shao W; Boritz E; Douek D; Fromentin R; Liegler T; Hoh R; Deeks SG; Hecht FM; Chomont N; Palmer S
Front Microbiol; 2019; 10():2214. PubMed ID: 31611857
[TBL] [Abstract][Full Text] [Related]
24. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
25. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy.
Gosselin A; Wiche Salinas TR; Planas D; Wacleche VS; Zhang Y; Fromentin R; Chomont N; Cohen ÉA; Shacklett B; Mehraj V; Ghali MP; Routy JP; Ancuta P
AIDS; 2017 Jan; 31(1):35-48. PubMed ID: 27835617
[TBL] [Abstract][Full Text] [Related]
26. Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.
Jenabian MA; Costiniuk CT; Mehraj V; Ghazawi FM; Fromentin R; Brousseau J; Brassard P; Bélanger M; Ancuta P; Bendayan R; Chomont N; Routy JP;
AIDS; 2016 Nov; 30(18):2777-2786. PubMed ID: 27677162
[TBL] [Abstract][Full Text] [Related]
27. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
Chéret A; Bacchus-Souffan C; Avettand-Fenoël V; Mélard A; Nembot G; Blanc C; Samri A; Sáez-Cirión A; Hocqueloux L; Lascoux-Combe C; Allavena C; Goujard C; Valantin MA; Leplatois A; Meyer L; Rouzioux C; Autran B;
J Antimicrob Chemother; 2015 Jul; 70(7):2108-20. PubMed ID: 25900157
[TBL] [Abstract][Full Text] [Related]
28. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4
Grau-Expósito J; Serra-Peinado C; Miguel L; Navarro J; Curran A; Burgos J; Ocaña I; Ribera E; Torrella A; Planas B; Badía R; Castellví J; Falcó V; Crespo M; Buzon MJ
mBio; 2017 Jul; 8(4):. PubMed ID: 28698276
[TBL] [Abstract][Full Text] [Related]
29. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
[TBL] [Abstract][Full Text] [Related]
30. Antiretroviral Therapy in Simian Immunodeficiency Virus-Infected Sooty Mangabeys: Implications for AIDS Pathogenesis.
Calascibetta F; Micci L; Carnathan D; Lawson B; Vanderford TH; Bosinger SE; Easley K; Chahroudi A; Mackel J; Keele BF; Long S; Lifson J; Paiardini M; Silvestri G
J Virol; 2016 Aug; 90(16):7541-7551. PubMed ID: 27279614
[TBL] [Abstract][Full Text] [Related]
31. Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.
Samri A; Charpentier C; Diallo MS; Bertine M; Even S; Morin V; Oudin A; Parizot C; Collin G; Hosmalin A; Cheynier R; Thiébaut R; Matheron S; Collin F; Zoorob R; Brun-Vézinet F; Autran B;
PLoS Pathog; 2019 May; 15(5):e1007758. PubMed ID: 31095640
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-7 promotes HIV persistence during antiretroviral therapy.
Vandergeeten C; Fromentin R; DaFonseca S; Lawani MB; Sereti I; Lederman MM; Ramgopal M; Routy JP; Sékaly RP; Chomont N
Blood; 2013 May; 121(21):4321-9. PubMed ID: 23589672
[TBL] [Abstract][Full Text] [Related]
33. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
[TBL] [Abstract][Full Text] [Related]
34. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
[TBL] [Abstract][Full Text] [Related]
35. Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals.
El-Diwany R; Breitwieser FP; Soliman M; Skaist AM; Srikrishna G; Blankson JN; Ray SC; Wheelan SJ; Thomas DL; Balagopal A
AIDS; 2017 Jun; 31(10):1405-1414. PubMed ID: 28358734
[TBL] [Abstract][Full Text] [Related]
36. Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.
Bachtel ND; Beckerle GA; Mota TM; Rougvie MM; Raposo RAS; Jones RB; Nixon DF; Apps R
AIDS Res Hum Retroviruses; 2019 Jan; 35(1):108-111. PubMed ID: 30198299
[TBL] [Abstract][Full Text] [Related]
37. α
Cheung KW; Wu T; Ho SF; Wong YC; Liu L; Wang H; Chen Z
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386290
[TBL] [Abstract][Full Text] [Related]
38. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
[TBL] [Abstract][Full Text] [Related]
39. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
[TBL] [Abstract][Full Text] [Related]
40. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
